Clinical Study

Effect of Spirulina Intervention on Oxidative Stress, Antioxidant Status, and Lipid Profile in Chronic Obstructive Pulmonary Disease Patients

Table 5

Effect of spirulina intervention at (500 × 4) mg dose on serum content of oxidants and antioxidants and on the activity of burst enzymes in COPD patients.

Parameters 0 days
(mean ± SD)
30 days
(mean ± SD)
60 days
(mean ± SD)
value value

Malondialdehyde (MDA) (nmoL/mL)3.78 ± 0.243.11 ± 0.252.43 ± 0.28 216.404 0.000*
Lipid hydroperoxide (nmoL/mL)3.63 ± 0.193.10 ± 0.232.44 ± .21 240.034 0.000*
Catalase (kU/L)31.53 ± 8.4136.12 ± 8.2142.25 ± 7.59 13.314 0.000*
Superoxide dismutase (SOD) (U/mL)67.25 ± 6.4374.76 ± 5.6480.83 ± 4.89 42.864 0.000*
Glutathione-S-transferase (GST) (U/mL)28.41 ± 4.0231.61 ± 3.7532.88 ± 3.42 11.350 0.000*
Glutathione (GSH) (nmoL/mL)279.3 ± 23.26316.76 ± 16.68 356.57 ± 11.71 140.565 0.000*
Vitamin C (mg/dL)0.76 ± 0.070.85 ± .060.98 ± .05 114.403 0.000*
Cholesterol (mg/dL)167.22 ± 10.33155.28 ± 7.45140.72 ± 14.90 41.244 0.000*
Triglyceride (TG) (mg/dL)172.10 ± 14.44166.50 ± 13.25161.34 ± 11.68 5.011 0.000*
High density lipoprotein (HDL) (mg/dL)42.21 ± 5.1743.16 ± 5.1544.69 ± 4.79 1.853 0.163

Statistically significant. Comparisons are made between day 0 versus day 30 and day 0 versus day 60.